Skip to content
← Lobby register
II
Other

Insulet International

🇪🇺 UNITED KINGDOMRegistered 23/12 staff
Disclosed budget
€50,000 — €99,999
Meetings 12mo
0
Policy files
0
Accredited passes
0

Recent meetings

No recorded meetings with EU commissioners.

Mission & Goals

Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes easier through the use of its Omnipod® product platform. The Omnipod® Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery (up to 72 hours), without the need to see or handle a needle.

EU Legislative Interests

European Health Data Space Artificial Intelligence Act Diabetes related policies Any regulation relating to medical devices & healthcare

Communication Activities

N/A

Interests Represented

Promotes their own interests or the collective interests of their members

Member Of

MedTech Europe www.medtecheurope.org EUDF https://www.eudf.org/

Organisation Members

MedTech Europe www.medtecheurope.org

Additional Information

The cost outlined above is reflective of activity and membership fee with MedTech Europe (our industry association)